Stockholders’ Equity (Details) - USD ($)				1 Months Ended				12 Months Ended
	Apr. 01, 2021	Jan. 06, 2020	Dec. 13, 2013	Jul. 01, 2021	Jan. 31, 2021	Jan. 02, 2021	Jan. 31, 2020	Dec. 31, 2021	Dec. 31, 2020	Aug. 09, 2016
Stockholders’ Equity (Details) [Line Items]
Preferred stock, shares authorized			5,000,000
Preferred stock, par value (in Dollars per share)			$ 1
Preferred stock, voting rights description								The holders of the preferred stock are entitled to fifty (50) votes for each share held.
Receive per share (in Dollars per share)								$ 1
Preferred stock shares outstanding								2,000,000	2,000,000
Preferred stock outstanding transactions description								Once any shares of Preferred Stock are outstanding, at least 51% of the total number of shares of Preferred Stock outstanding must approve the following transactions:
Common stock shares issued		110,000			130,000
Aggregate fair value (in Dollars)		$ 24,200			$ 52,000
Price per share (in Dollars per share)		$ 0.22			$ 0.4
Stock-based compensation expense (in Dollars)					$ 52,000			$ 56,180	$ 24,231
Share issued	60,000
Shares valued at fair value (in Dollars)	$ 37,800
Share price (in Dollars per share)	$ 0.63
Intangible assets (in Dollars)	$ 37,800
Number of options outstanding								1,575,000
Number of options vested and exercisable								1,300,000
Unvested stock-based compensation expense (in Dollars)								$ 92,335
Aggregate intrinsic value (in Dollars)								$ 1,400
Share per price (in Dollars per share)								$ 0.775
2016 Plan [Member]
Stockholders’ Equity (Details) [Line Items]
Reserved shares of common stock										10,000,000
Stock option awards								325,000	75,000
Stock option exercisable								125,000	75,000
Future issuance shares								9,675,000	9,925,000
2016 Plan [Member] | Director of Real Estate [Member]
Stockholders’ Equity (Details) [Line Items]
Stock option to purchase				125,000
Exercise price (in Dollars per share)				$ 1
Stock option description				The grant date of the option was July 1, 2021 and the option expires on July 1, 2031. The option vests as to (i) 25,000 of such shares on July 1, 2021; and (ii) as to 10,000 of such shares on July 1, 2022 and each year thereafter through July 1, 2031. The vesting of the Option pursuant to the Vesting Schedule hereof is earned only by continuing as a service provider at the will of the Company. The fair value of this option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions: dividend yield of 0%; expected volatility of 119%; risk-free interest rate of 1.48%; and an estimated holding period of 10 years. In connection with these options, the Company valued these options at a fair value of $69,677 and will record stock-based compensation expense over the vesting period.
2016 Plan [Member] | Equity Option [Member]
Stockholders’ Equity (Details) [Line Items]
Purchase of common stock		125,000
Exercise price (in Dollars per share)		$ 1
Stock option description		The grant date of the option was January 6, 2020 and the option expires on January 6, 2030. The option vests as to (i) 35,000 of such shares on January 6, 2020; and (ii) as to 10,000 of such shares on January 6, 2021 and each year thereafter through January 6, 2029. The fair value of this option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions: dividend yield of 0%; expected volatility of 110%; risk-free interest rate of 1.81%; and an estimated holding period of 10 years. In connection with these options, the Company valued these options at a fair value of $23,388 and will record stock-based compensation expense over the vesting period. In July 2020, this employee was terminated and 90,000 unvested options were cancelled.
2014 Plan [Member]
Stockholders’ Equity (Details) [Line Items]
Terms of plan, description								The Company also continues to maintain its 2014 Equity Compensation Plan (the “2014 Plan”), pursuant to which 1,250,000 previously awarded stock options are outstanding. The 2014 Plan has been superseded by the 2016 Plan. Accordingly, no additional shares subject to the existing 2014 Plan will be issued and the 1,250,000 shares issuable upon exercise of stock options will be issued pursuant to the 2014 Plan, if exercised.
Stock option to purchase								1,250,000	1,175,000
Board of Directors [Member]
Stockholders’ Equity (Details) [Line Items]
Stock-based compensation expense (in Dollars)							$ 24,200
Chief Operating Officer [Member] | 2016 Plan [Member]
Stockholders’ Equity (Details) [Line Items]
Purchase of common stock						125,000
Exercise price (in Dollars per share)						$ 1
Stock option description						The grant date of the option was January 1, 2021 and the option expires on January 1, 2031. The option vests as to (i) 25,000 of such shares on January 1, 2021; and (ii) as to 10,000 of such shares on January 1, 2022 and each year thereafter through January 1, 2031. The fair value of this option grant was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions: dividend yield of 0%; expected volatility of 117%; risk-free interest rate of 0.93%; and an estimated holding period of 10 years. In connection with these options, the Company valued these options at a fair value of $48,677 and will record stock-based compensation expense over the vesting period.